National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

chloroquinoxaline sulfonamide
A chlorinated heterocyclic sulfanilamide with potential antineoplastic activity and potential immunosuppressive activity. Chloroquinoxaline sulfonamide poisons topoisomerase II alpha and topoisomerase II beta, thereby causing double-stranded breaks in DNA, accumulation of unrepaired DNA, and apoptosis. This agent also exhibits lymphotoxicity by inhibiting lymphocyte activation in a cell cycle-specific manner. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:chlorosulfaquinoxaline
chlorsulfaquinoxaline
Abbreviation:CQS
Chemical structure name:benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-



Previous:chimeric anti-phosphotidylserine monoclonal antibody, CHIR-265, chk1 inhibitor PF-477736, chlorambucil, chlorhexidine
Next:chlorozotocin, chlorpromazine, chlorzoxazone, cholecalciferol, cholecalciferol/d-alpha tocopherol/L-selenomethionine/green tea extract/saw palmetto berry extract/daidzein/genistein/lycopene prostate health supplement

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov